LENSAR, Inc.
NCM: LNSRLive Quote
About LENSAR, Inc.
Healthcare
Medical Devices
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
📊 Fundamental Analysis
LENSAR, Inc. demonstrates a profit margin of -58.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported -4.2% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -1069.4%, which indicates that capital utilization is currently under pressure.
At a current price of $5.70, LNSR currently trades near the bottom of its 52-week range (4%), indicating potential value or weakness (Range: $5.33 - $14.31).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$68.87M
Trailing P/E
--
Forward P/E
-8.03
Beta (5Y)
0.98
52W High
$14.31
52W Low
$5.33
Avg Volume
107K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App